Palo Alto – August 30, 2026 – WCP is delighted to release the MedTech Market Update, Q2 2026, authored by senior banker Juliesta Sylvester PhD, and by analyst Ted Celentino.
The report covers the following key points and more:
- The global MedTech sector is advancing from post-pandemic recovery into sustained expansion, propelled by aging demographics and capital concentration in high-margin categories such as robotic surgery, minimally invasive tech, and specialized surgical instruments.
- M&A activity in Q2 2026 was heavily driven by corporate strategics seeking transformative scale, as evidenced by large-scale platform acquisitions like Danaher’s $9.9B purchase of Masimo to secure AI-enabled patient monitoring and acute care diagnostic capabilities.
- Venture investment demonstrated renewed institutional conviction with quarterly funding surging to $3.8B, directing selective capital toward high-growth frontiers in AI diagnostics, digital health, and precision medicine.
- Artificial intelligence is rapidly expanding across the MedTech value chain, transitioning from clinical decision support into core operational functions including real-world evidence generation and predictive supply-chain management.
- Accelerating care migration into at-home diagnostics and clinical wearables is converging with tightened regulatory frameworks, such as the FDA’s QMSR enforcement, reshaping device design, lifecycle risk management, and commercial go-to-market strategies.
Get the report here:
Woodside Capital Partners is a leading corporate finance advisory firm for tech companies in M&A and financings in the $30M –$500M enterprise value segment. The firm has worked with extraordinary entrepreneurs and investors since 2001, providing ultra-personalized service to its clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain and transaction experience in these and other sectors: Artificial Intelligence, CyberSecurity, HR Tech, Digital Advertising and Marketing, Autonomous Vehicles, ADAS, Computer Vision, Aerospace and Defense, CloudTech, Enterprise Software, IT Services, Information Security, FinTech, Internet of Things, Networking / Infrastructure, Robotics, Semiconductors, Quantum, Energy Storage, Digital Health & Virtual Care, Diagnostic, Medical Devices & Precision Medicine, Healthcare IT & Data Analytics Platforms, AI & Automation in Clinical Decision Support, Revenue Cycle Management & Financial Ops, Behavioral & Mental Health Tech, Value-Based Care & Preventive/Wellness Platforms, Healthcare Infrastructure & Cybersecurity. Woodside Capital Partners is a specialist in cross-border transactions, and has extensive relationships among venture capitalists, private equity investors, and corporate executives from Global 1000 companies.
Questions? Please contact Juliesta Sylvester PhD, Managing Director, Woodside Capital Partners at jsylvester@woodsidecap.com.